Cabot (CBT) Expected to Announce Earnings on Tuesday

Cabot (NYSE:CBT) is expected to announce its Q1 2026 results after the market closes on Tuesday, February 3rd. Analysts expect the company to announce earnings of $1.40 per share and revenue of $889.1120 million for the quarter. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Investors can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:00 AM ET.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The business had revenue of $899.00 million for the quarter, compared to analyst estimates of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm’s quarterly revenue was down 10.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.80 earnings per share. On average, analysts expect Cabot to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cabot Stock Performance

Shares of CBT stock opened at $72.19 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.61 and a quick ratio of 1.08. The firm has a 50-day moving average of $68.13 and a 200-day moving average of $71.69. Cabot has a one year low of $58.33 and a one year high of $89.16. The company has a market cap of $3.82 billion, a P/E ratio of 12.01, a P/E/G ratio of 3.78 and a beta of 0.89.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Friday, November 28th were given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Friday, November 28th. Cabot’s dividend payout ratio (DPR) is currently 29.95%.

Analysts Set New Price Targets

CBT has been the subject of a number of analyst reports. JPMorgan Chase & Co. cut their price target on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a report on Friday, November 28th. UBS Group raised their target price on Cabot from $65.00 to $74.00 and gave the stock a “neutral” rating in a research note on Monday, January 12th. Jefferies Financial Group reiterated a “buy” rating and set a $81.00 price target on shares of Cabot in a research report on Thursday, January 8th. Mizuho raised their price objective on shares of Cabot from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Cabot has a consensus rating of “Hold” and a consensus target price of $72.25.

Institutional Trading of Cabot

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CBT. Danske Bank A S bought a new position in shares of Cabot in the 3rd quarter worth about $38,000. Geneos Wealth Management Inc. grew its holdings in Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Caitong International Asset Management Co. Ltd increased its stake in shares of Cabot by 709.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock valued at $41,000 after purchasing an additional 468 shares in the last quarter. Advisory Services Network LLC purchased a new position in shares of Cabot during the third quarter valued at approximately $57,000. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Cabot by 344.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock worth $61,000 after purchasing an additional 630 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.